Even small bleeds after minor stroke raise death risk in this trial analysis

A small bleed inside the brain after a stroke can feel like a minor setback. But new analysis of trial data suggests these bleeds carry a heavier price than doctors previously thought. This review looked at 865 patients who had a minor ischemic stroke and received treatment within 12 hours of symptoms starting. These patients had a visible blockage in their blood vessels but mild symptoms on standard scales. The team tracked what happened to them over 90 days. They found that any bleeding inside the brain occurred in 102 of these patients. While most of these were tiny spots, the presence of bleeding was tied to a much higher risk of dying within three months. Mortality rose from 1.8 percent without bleeding to 9.8 percent with bleeding. The analysis adjusted for age, sex, and how quickly treatment started. Even when researchers accounted for these factors, the link between bleeding and death remained strong. The study also noted that rates of bleeding were slightly higher in the group receiving tenecteplase compared to standard care. However, the difference in serious bleeding symptoms between the two treatment groups was not statistically significant. This does not mean the drug is unsafe. It means that even minor bleeding events matter for survival. Doctors must weigh the benefits of clot-busting drugs against the risk of any internal bleeding. Patients with mild strokes should know that a small bleed can change their long-term outlook.